Merck KGaA (OTCMKTS:MKGAF) Reaches New 52-Week High – Time to Buy?

Merck KGaA (OTCMKTS:MKGAFGet Free Report) shares hit a new 52-week high during trading on Friday . The company traded as high as $166.2620 and last traded at $166.2620, with a volume of 25 shares changing hands. The stock had previously closed at $163.71.

Merck KGaA Stock Up 0.3%

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $21.22 billion, a PE ratio of 25.07 and a beta of 0.96. The stock has a 50-day moving average of $137.83 and a 200 day moving average of $141.46.

About Merck KGaA

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Recommended Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.